Nicotine
This medicine should always be taken exactly as described in the patient leaflet or as advised by a doctor or pharmacist.
The medicine is used to alleviate withdrawal symptoms and reduce nicotine cravings that occur when trying to quit smoking or reduce the number of cigarettes smoked, in an attempt to quit smoking. This treatment is intended for adult smokers aged 18 and over.
Nicorette Fruit, 2 mg, lozenges are suitable for use by smokers with a low level of nicotine dependence, i.e., those who smoke their first cigarette of the day more than 30 minutes after waking up or who smoke 20 or fewer cigarettes per day.
Nicorette Fruit, 4 mg, lozenges are suitable for use by smokers with a high level of nicotine dependence, i.e., those who smoke their first cigarette of the day within 30 minutes of waking up or who smoke more than 20 cigarettes per day.
The medicine can help with immediate quitting or with reducing the number of cigarettes smoked before finally quitting. If the patient thinks they can quit immediately, they should do so. However, if they think it will be too difficult, they may want to reduce the number of cigarettes smoked as a first step before achieving complete abstinence. More detailed information is provided in section 3 "How to use Nicorette Fruit".
Nicorette Fruit alleviates withdrawal symptoms that occur after quitting smoking, including nicotine cravings. When nicotine from tobacco is suddenly stopped, various unpleasant feelings, called withdrawal symptoms, develop, such as irritability, feelings of anger or depression, anxiety, restlessness, decreased concentration, increased appetite or weight gain, strong desire to smoke (cravings), insomnia or sleep disturbances. The nicotine in Nicorette Fruit can prevent these unpleasant feelings or reduce their intensity and reduce the desire to smoke.
To increase the chances of a successful quit attempt, it is also recommended to use counseling and behavioral support.
The patient should consult a doctor if they have any of the following conditions. It may be possible for the patient to use Nicorette Fruit, but they must first consult a doctor if they have:
Non-smokers should not use the medicine.
Lozenges may pose a choking hazard. The medicine should be used with caution if the patient has problems swallowing solids or liquids, or if they frequently cough while swallowing or after swallowing.
An appropriate dose for adults, given to children, may cause serious poisoning, and even lead to death. It is essential, therefore, to keep Nicorette Fruit out of sight and reach of children.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. This is especially important if they are taking medicines that contain:
The patient should not eat or drink while taking the lozenges.
It is very important to quit smoking during pregnancy, as it can lead to fetal growth restriction. It can also cause miscarriage or stillbirth. It is best for pregnant women to quit smoking without using nicotine-containing medicines. However, if they are unable to do so, they may use Nicorette Fruit, but only after consulting their doctor, primary care physician, or a doctor specializing in smoking cessation treatment.
Nicorette Fruit should not be taken during breastfeeding, as nicotine passes into breast milk and may affect the baby. If a doctor recommends using Nicorette Fruit, the lozenge should be taken immediately after breastfeeding and no sooner than 2 hours before starting breastfeeding.
Smoking increases the risk of infertility in women and men. The effect of nicotine on fertility is unknown.
No effects of the medicine on the ability to drive or use machines have been observed.
Nicorette Fruitcontains less than 1 mmol of sodium (23 mg) per lozenge, which means the medicine is considered "sodium-free". The medicine also contains small amounts of sulfites from the flavor, which can rarely cause severe hypersensitivity reactions and bronchospasm. Nicorette Fruit contains polysorbate, which can cause allergic reactions.
This medicine should always be taken exactly as described in the leaflet or as advised by a doctor or pharmacist. In case of doubt, the patient should consult a doctor or pharmacist.
The way to use Nicorette Fruit depends on whether the patient:
If the patient feels they can do so, they should quit smoking completely. They should then follow the instructions for immediate quitting, described above. The patient should do this as soon as possible. If the attempt to quit smoking completely is unsuccessful within 6 months of starting treatment, the patient should consult a healthcare professional.
Do not exceed the recommended dose. Follow the instructions carefully and do not use more than 15 lozengesper day (24 hours).
If the patient needs to use the medicine for more than 9 months in total, they should consult a doctor.
Adolescents aged 12-17
Nicorette Fruit should only be used on the advice of a doctor.
Children under 12
The medicine should not be given to children under 12 years old.
[Polypropylene container]
OPENING
CLOSING
[Cardboard box]
Opening:
Closing: push the top part of the box.
The medicine is intended for administration to the oral mucosa. It should be placed in the mouth and allowed to dissolve and release nicotine, which can then be absorbed into the body through the lining of the mouth.
One lozenge should be placed in the mouth and moved from time to time from one side of the mouth to the other until it is completely dissolved. This should take less than 20 minutes. The lozenges should not be chewed or swallowed whole. The patient should not eat or drink while a lozenge is in the mouth.
If the patient:
If the patient smokes while taking Nicorette Fruit, nicotine overdose may occur.
If the medicine is taken by a child or if the patient uses more Nicorette Fruit than recommended, they should immediatelyconsult a doctor or go to the nearest hospital.
Doses of nicotine tolerated during treatment by adult smokers may cause severe poisoning and may be fatal in children.
Symptoms of overdose are: nausea (vomiting), vomiting, increased saliva production, abdominal pain, diarrhea, excessive sweating, headache, dizziness, and significant weakness. After these symptoms, large doses may cause low blood pressure, weak and irregular pulse, breathing difficulties, exhaustion, vascular collapse, and generalized seizures.
If the patient has any further questions about the use of this medicine, they should consult a doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some of the side effects that occur when quitting smoking may be withdrawal symptoms caused by reducing the nicotine dose. Possible symptoms include:
the following:
Most side effects occur in the early stages of treatment. During the first few days of treatment, mouth and throat irritation may occur, but most patients adapt to the treatment with the disappearance of this symptom during continued therapy.
Very common: may affect more than 1 in 10 people:
Common: may affect up to 1 in 10 people:
Uncommon: may affect up to 1 in 100 people:
Rare: may affect up to 1 in 1,000 people:
Unknown: frequency cannot be estimated from the available data:
If the patient experiences any side effects, including any possible side effects not listed in the leaflet, they should tell their doctor or pharmacist.
Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, more information can be collected on the safety of the medicine.
The active substance is nicotine. One lozenge contains 2 mg or 4 mg of nicotine (as nicotine bitartrate).
The other ingredients are:
Nicorette Fruit lozenges do not contain sugar.
Oval lozenge, white to almost white, marked with "n" on one side and "2" or "4" on the other, approximately 14 x 9 x 7 mm in size.
Pack sizes: each polypropylene container contains 20 lozenges. Packs may contain 1 container, 4 containers, or 8 containers.
Each cardboard box contains 40 lozenges. Packs may contain 1 box, 2 boxes, or 4 boxes.
Not all pack sizes may be marketed.
McNeil AB, PO Box 941, 251 09 Helsingborg, Sweden
McNeil AB, Norrbroplatsen 2, 251 09 Helsingborg, Sweden
Johnson & Johnson Consumer NV/SA, Michel De Braeystraat 52, 2000 Antwerp, Belgium
Johnson & Johnson GmbH, Johnson & Johnson Platz 2, 41470 Neuss, Germany
For more information, please contact:
email: consumer-pl@kenvue.com
Date of last revision of the leaflet:January 2025
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.